TRADING QUOTES 5:31 AM May 23, 2022
IPO Terms Details Business Combination Related Articles SEC Filings
SPAC Name : Biotech Acquisition Company
Total Public Proceeds at IPO($mm): 230.0
%Held in Trust: 100.0
$Held in Trust per Unit: $ 10.00
Mgmt's Sector Expertise/Focus: BioTech
IPO Date: 2021-01-26
Months to Complete: 24
Deadline Date: 2023-01-28
Unit Structure (BIOTU)
Share (BIOT): 1 Class A Ordinary Share
Warrant (BIOTW) 1/2 Warrant
Right()
Public Warrant Terms:
Exercise Price: 11.5
Redemption Price: Cash/Cashless: $18.00
Redemption: Cash, Cashless or for Shares Mgmt's Discretion
Underwriters:
Book-runner(s): Cantor Fitzgerald
Co-Manager(s):
Fees (Upfront/Deferred): 2.0%/3.5%
Lawyers:
Issuer's Counsel: Ellenoff Grossman & Schole LLP
Underwriter's Counsel: Reed Smith LLP
Additional Terms: 1. Crescent term: $9.20 2. Limitation on redemption rights: 15%
SPAC Name: Biotech Acquisition Company
CURRENT FUNDS in TRUST: $230,163,023*
EST. PRO RATA AMOUNT IN TRUST: $10.01*
IMPLIED ENTERPRISE VALUE: $352.8 million
RECORD DATE: 2022-03-28
SHAREHOLDER VOTE DATE: 2022-06-01
SPAC NameSource: SEC.gov filings and SPAC Insider estimates
TRADING QUOTES       Business CombinationIPO Terms Details SPAC name: %spacname% CURRENT FUNDS in TRUST: $%ending_trust_ball%* EST. PRO RATA AMOUNT IN TRUST: $%implied_cash_per_share%* IMPLIED ENTERPRISE VALUE: %impliedenterprisevalue% RECORD DATE: %businesscombinationrecorddate% SHAREHOLDER VOTE DATE: %businesscombinationshareholdervotedate% Source: SEC.gov filings and SPAC Insider estimates SPAC name: %spacname% Total Public Proceeds at IPO ($mm): %total% % Held in Trust:
Read More
To access this page, you must purchase a database subscription via the Subscription Store Tab or log in.